In the study, C8-ceramide treatment may cause the switch of SOD1/SOD2 expression and the up-regulation of cyclin D1, which could sensitize NSCLC cells towards proliferation inhibition and apoptosis, and we herein presented a proposed model of the pathway accordingly (Figure 7). The gene discussed is SOD2; the disease is non-small cell lung carcinoma.